Top Story

Five ophthalmology clinical trial updates you might have missed

September 8, 2017

Ophthalmic clinical trials of products for diabetic macular edema and Leber’s hereditary optic neuropathy, as well as geographic atrophy and pain and inflammation in cataract surgery, all moved forward in the month of August.

Here are the top five clinical trial updates for the month as reported on

Usher syndrome candidate receives orphan drug designation

September 5, 2017
The FDA and the European Medicines Agency have granted orphan drug designation to QRX-421, an investigational drug for Usher syndrome, according to a press release from…

Top five ophthalmology stories of August

September 3, 2017
The rare solar eclipse that passed through the United States in August led ophthalmology-related news for the month, which also included FDA advancements and business…

Five FDA ophthalmology actions in August

September 1, 2017
The FDA moved forward on multiple ophthalmology-related products in the month of August. Here are the top five advancements as reported on 1.
More Headlines »
Original Article

Refractive Outcomes of 20 Eyes Undergoing ICL Implantation for Correction of Hyperopic Astigmatism

Journal of Refractive Surgery, September 2017, Volume 33 Issue 9
To analyze 1-week, 1-month, and 12-month postoperative refractive outcomes of eyes that under-went ICL implantation to…
More »

Innovation or Interference? The Future of Generic Ophthalmics in a Challenging Regulatory Environment: Generic Ophthalmic Medications ARE Different!

This activity is supported by an educational grant from Ista Pharmaceuticals.

An experienced research pharmacologist with expertise in the discovery and marketing of ophthalmic medications offers…
More »
Resource Centers
American Society of Retina Specialists Meeting

American Society of Retina Specialists Meeting

Meeting News Coverage

FDA expands indication for implantable miniature telescope

October 27, 2014
More »